Detalhe da pesquisa
1.
Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126.
Cancer
; 129(5): 685-696, 2023 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36579470
2.
Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203.
Gynecol Oncol
; 175: 176-181, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37393743
3.
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
J Neurooncol
; 155(3): 363-372, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34761331
4.
Do reminder emails and past due notifications improve patient completion and institutional data submission for patient-reported outcome measures?
Qual Life Res
; 30(1): 81-89, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-32894431
5.
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
N Engl J Med
; 376(5): 417-428, 2017 02 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28146658
6.
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
N Engl J Med
; 374(14): 1344-55, 2016 Apr 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27050206
7.
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy.
Gynecol Oncol
; 154(1): 183-188, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31104905
8.
Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial.
Cancer
; 123(3): 485-493, 2017 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27861753
9.
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma.
J Neurooncol
; 131(1): 193-199, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27770279
10.
Xerostomia health-related quality of life: NRG oncology RTOG 0537.
Qual Life Res
; 25(9): 2323-33, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-26914104
11.
The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial.
Qual Life Res
; 23(6): 1841-58, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24492945
12.
Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial.
JAMA
; 311(13): 1300-7, 2014 Apr 02.
Artigo
Inglês
| MEDLINE | ID: mdl-24691606
13.
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial.
Eur Urol
; 85(4): 373-381, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36710205
14.
Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 2024 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38483412
15.
Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial.
Int J Radiat Oncol Biol Phys
; 2024 May 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38739047
16.
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712.
Eur Urol Oncol
; 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38641541
17.
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial.
Eur Urol Oncol
; 2024 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-38302323
18.
Integrating Artificial Intelligence and Machine Learning Into Cancer Clinical Trials.
Semin Radiat Oncol
; 33(4): 386-394, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37684068
19.
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.
J Clin Oncol
; 41(6): 1285-1295, 2023 02 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36260832
20.
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 116(4): 770-778, 2023 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36592721